Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 72162-1599

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 72162-1599). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Duloxetine 01)

FDA Label Image

Figure 1 (Duloxetine 02)

FDA Label Image

Figure 2 (Duloxetine 03)

Figure 2 (Duloxetine 03)
Proportion of Patients with Relapse: The provided text includes some numbers and labels related to the proportion of patients with relapse, although it is not clear what these numbers represent. The text also mentions a treatment comparison between a placebo and a medication called "Duloxetine Delayed-Release Capsules". Additionally, there is a time indication in days related to the "Time from Randomization to Relapse". Without more context or a clear explanation, it is difficult to provide a more detailed description or analysis.*
FDA Label Image

Figure 3 (Duloxetine 04)

FDA Label Image

Figure 4 (Duloxetine 05)

FDA Label Image

Figure 5 (Duloxetine 06)

FDA Label Image

Figure 6 (Duloxetine 07)

FDA Label Image

Figure 7 (Duloxetine 08)

Figure 7 (Duloxetine 08)
Not available.*
FDA Label Image

Figure 8 (Duloxetine 09)

Figure 8 (Duloxetine 09)
Percentage of Patients Improved: The text provided appears to be incomplete. It mentions Pacabo and DUL 120 mg once daily, but does not provide clear information about the percentage of patients improved or the scale used for measurement. Therefore, the available information is not sufficient to generate a useful description.*
FDA Label Image

Figure 9 (Duloxetine 10)

FDA Label Image

Figure 10 (Duloxetine 11)

FDA Label Image

Label (Lbl721621599)

Label (Lbl721621599)
This appears to be the description of a medication called Duloxetine Hydrochloride in the form of delayed-release capsules. Each capsule contains 67.3 mg of the active ingredient. The National Drug Code (NDC) for this product is 72162-1599-9. It is equivalent to 60 mg of Duloxetine. The medication should be kept out of reach of children and stored at a temperature between 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). It should be dispensed in a tightly closed container and is only available with a prescription. The manufacturer provides a Medication Guide for patients that can be obtained at the link provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.